Delivery Order SPE2DB22D1103-SPE2DB24FTLK7

Award Date 5/30/24
Potential Completion Date 5/31/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,046.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
This federal contract award, valued at $1,794.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication used for various medical conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $3,583.36, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of HUMIRA (CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to federal agencies. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,234.24 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,318.23 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $1,174.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA PEN 40 MG/0.8 MLS, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, valued at $3,476.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for the delivery of Humira Pen 40 mg/0.8 mls to the U.S. government. The contract, valued at $1,847.20, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.37 firm fixed-price delivery order contract is for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. The contract has an ultimate completion date of May 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award, valued at $7,735.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTLK7
    Delivery Order

This federal contract award, valued at $1,847.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Humira(CF) Pen 40 mg/0.4 mLs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The contract does not have a set-aside designation and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 8/29/24, 9:50 AM